Qing Chang
Beijing University of Chinese Medicine(CN)Dalian Medical University(CN)West China Medical Center of Sichuan University(CN)Weatherford College(US)Second Affiliated Hospital of Chongqing Medical University(CN)Cancer Research Center(US)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)Disco (Germany)(DE)Chongqing Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Osteoarthritis Treatment and Mechanisms, Cancer, Hypoxia, and Metabolism, Hippo pathway signaling and YAP/TAZ, Cancer-related molecular mechanisms research
Most-Cited Works
- → Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade(2016)1,003 cited
- → Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance(2017)908 cited
- → Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls(2013)769 cited
- → Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer(2014)722 cited
- → KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer(2019)593 cited
- → Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression(2015)540 cited